Latest Cannabinoid Stories

The new research suggests potential target for drugs to combat alcohol addictionIn findings that should finally put to rest a decade of controversy in the field of neurobiology, a team at The Scripps Research Institute has found decisive evidence that a specific neurotransmitter system"”the endocannabinoid system"”is active in a brain region known to play a key role in the processing of memory, emotional reactions, and addiction formation. The new study also shows that this system can...

OAKLAND, Calif., April 8 /PRNewswire/ -- ** 'Cannabis - The Medicine Plant' Forum The 6th Annual National Clinical Conference on Cannabis Therapeutics April 15-17, 2010, Crown Plaza Hotel, 801 Greenwich Ave. , Warwick, RI ** "Harborside Health Center, a nonprofit medical marijuana dispensary in Oakland, Calif., is looked upon as a model of how others could operate."...

First results in United States in 20 years from clinical trials of smoked cannabisResearchers from the University of California's Center for Medicinal Cannabis Research (CMCR) have found "reasonable evidence that cannabis is a promising treatment" for some specific, pain-related medical conditions. Their findings, presented Feb. 17 to the California legislature and public, are included in a report available on the CMCR web site at http://www.cmcr.ucsd.edu"We focused on...

WESTON, Mass., Nov. 9 /PRNewswire/ -- Groundbreaking articles in current issues of Journal of Opioid Management, for the first time explore, in depth, the emergence of cannabinoid medicine, its challenges for health care providers and its potential benefits for patients. In these important articles, University of Washington authors, Sunil Aggarwal, PhD who is a member of the prestigious Medical Scientist Training Program and who conducted the article's research and Gregory T. Carter, MD,...

Use of cannabinoids (marijuana) could assist in the treatment of post-traumatic stress disorder patients. This is exposed in a new study carried out at the Learning and Memory Lab in the University of Haifa's Department of Psychology. The study, carried out by research student Eti Ganon-Elazar under the supervision of Dr. Irit Akirav, was published in the prestigious Journal of Neuroscience.In most cases, the result of experiencing a traumatic event - a car accident or terror attack - is the...

Chemicals found in marijuana could be linked to a possible cure for prostate cancer.Ines Diaz-Laviada and colleagues from the University of Alcala in Madrid found that chemicals in cannabis stopped the growth of prostate cancer cells in laboratory tests.Additionally, researchers found that the chemicals derived from cannabis helped shrink the size of prostate cancer tumors in mice."Cannabinoids can stop the division and growth of prostate cancer cells and could become a target for new...

Research has implications for medical use of drug and concepts of chronic pain Imagine that you're working on your back porch, hammering in a nail. Suddenly you slip and hit your thumb instead "” hard. The pain is incredibly intense, but it only lasts a moment. After a few seconds (and a few unprintable words) you're ready to start hammering again.How can such severe pain vanish so quickly? And why is it that other kinds of equally terrible pain refuse to go away, and instead torment...

A new study published by University of Leicester researchers has found "convincing evidence" that cannabis smoke damages DNA in ways that could potentially increase the risk of cancer development in humans.Using a newly developed highly sensitive liquid chromatography-tandem mass spectrometry method, the University of Leicester scientists found clear indication that cannabis smoke damages DNA, under laboratory conditions.They have now published the findings in the journal Chemical...

--By Avoiding the CNS, These Compounds May Be Free of the Side Effects Associated with Traditional Cannabinoid Compounds-- RESEARCH TRIANGLE PARK, N.C., April 1 /PRNewswire/ -- CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system (CNS), today announced issuance of a new U.S. patent covering its novel compounds that selectively target peripheral cannabinoid receptors. By avoiding the CNS, these...

ISELIN, N.J., Feb. 18 /PRNewswire-FirstCall/ -- Pharmos Corporation (Nasdaq: PARS) announced today that it has entered into an agreement with an Israel based company, Reperio Pharmaceuticals Ltd. (Reperio) for the sale of the patent rights and technical know how related to the compound known as PRS-639,058 and some follow on molecules. These CB2-selective cannabinoids are synthetic compounds which belong to the class of nonclassical cannabinoids and thus display fewer of the undesired...